Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Geisler

Showing results (1-10 of 310) with videos related to

Pageof 31
Sort By:
MMW Fortschritte Der Medizin|July 3, 2016
[Not Available]Tobias Geisler
Thrombosis and Haemostasis|November 2, 2021
Insights into Release of Interleukin-1β from PlateletsTobias Geisler
Thrombosis and Haemostasis|September 23, 2024
De-escalation of DAPT-A Potential Strategy for Treating Ticagrelor-Related Dyspnea?Tobias Geisler
MMW Fortschritte Der Medizin|July 3, 2016
[Not Available]Tobias Geisler
European Cardiology|July 31, 2024
Antiplatelet Treatment With Dual Pathway Inhibition: A Pathway of Consistency?Tobias Geisler
International Journal of Cardiology|December 19, 2017
PAR-4 - The PARagon of protease-activated receptors?Tobias Geisler
JACC. Cardiovascular Interventions|October 15, 2025
Postprocedural Measurement of Hemostasis to Define Long-Term Post-TAVR Bleeding Risk: Ready for Individualized Risk Assessment?Tobias Geisler
Seminars in Thrombosis and Hemostasis|February 18, 2016
Inflammatory Contribution of Platelets Revisited: New Players in the Arena of InflammationMadhumita Chatterjee, Tobias Geisler
MMW Fortschritte Der Medizin|June 15, 2011
[Current and future therapies for prophylaxis of thromboembolism in atrial fibrillation]Tobias Geisler, Meinrad Gawaz
Current Vascular Pharmacology|January 19, 2018
What is the Role of Cangrelor in Patients Undergoing PCI?Michal Droppa, Tobias Geisler
Pageof 31

Showing results (1-10 of 310) with videos related to

Sort By:
Pageof 31
MMW Fortschritte Der Medizin|July 3, 2016
[Not Available]Tobias Geisler
Thrombosis and Haemostasis|November 2, 2021
Insights into Release of Interleukin-1β from PlateletsTobias Geisler
Thrombosis and Haemostasis|September 23, 2024
De-escalation of DAPT-A Potential Strategy for Treating Ticagrelor-Related Dyspnea?Tobias Geisler
MMW Fortschritte Der Medizin|July 3, 2016
[Not Available]Tobias Geisler
European Cardiology|July 31, 2024
Antiplatelet Treatment With Dual Pathway Inhibition: A Pathway of Consistency?Tobias Geisler
International Journal of Cardiology|December 19, 2017
PAR-4 - The PARagon of protease-activated receptors?Tobias Geisler
JACC. Cardiovascular Interventions|October 15, 2025
Postprocedural Measurement of Hemostasis to Define Long-Term Post-TAVR Bleeding Risk: Ready for Individualized Risk Assessment?Tobias Geisler
Seminars in Thrombosis and Hemostasis|February 18, 2016
Inflammatory Contribution of Platelets Revisited: New Players in the Arena of InflammationMadhumita Chatterjee, Tobias Geisler
MMW Fortschritte Der Medizin|June 15, 2011
[Current and future therapies for prophylaxis of thromboembolism in atrial fibrillation]Tobias Geisler, Meinrad Gawaz
Current Vascular Pharmacology|January 19, 2018
What is the Role of Cangrelor in Patients Undergoing PCI?Michal Droppa, Tobias Geisler
Pageof 31